Obiettivo
Within only six months, over 7.4 million people have been diagnosed with SARS-CoV-2. In the most severely hit countries, more than 10% of infected patients have received treatment in Intensive Care Units (ICUs). Insufficient data and limited knowledge on the disease as well as the lack of tools to support the intensivist in making accurate, timely and informed decisions has led to high mortality rates.
Continuous surveillance, the collection and intelligent analysis of data from many sources, including ventilators and electrical impedance tomography, would allow intensivists to decide on the best suitable treatment to accelerate the recovery of the often comorbid COVID-19 patients, while reducing the burden on clinical staff and healthcare costs. This information would also increase our understanding of the yet unknown course of disease, supporting other stakeholders in the quest for new therapies.
In ENVISION, our multidsciplinary public-private consortium will advance an innovative digital tool, Sandman.MD a real-time and plug-and-play monitoring app, to an intelligent decision-support system for monitoring, prediction and treatment of COVID-19 patients in ICUs – the Sandman.ICU – reaching Technology Readiness Level 9 and ready for CE marking by the end of the project. The app has been developed by our SME partner app@work and successfully introduced by several hospitals in Germany for use during the perioperative period. Sandman.ICU will be integrated into an AI-driven data analytics suite with predictive modelling tools and enhanced with a smart alert functionality. The digital tool will be validated and demonstrated in 14 hospitals across Europe. Our Health Technology Assessment expert partner will demonstrate the economic and societal value of Sandman.ICU while an experienced SME will manage the innovation process in view of an immediate market uptake. The rollout will be supported by the European Society of Anaesthesiology and Intensive Care.
Campo scientifico
CORDIS classifica i progetti con EuroSciVoc, una tassonomia multilingue dei campi scientifici, attraverso un processo semi-automatico basato su tecniche NLP.
CORDIS classifica i progetti con EuroSciVoc, una tassonomia multilingue dei campi scientifici, attraverso un processo semi-automatico basato su tecniche NLP.
Parole chiave
Programma(i)
Invito a presentare proposte
H2020-SC1-PHE-CORONAVIRUS-2020-2
Vedi altri progetti per questo bandoBando secondario
H2020-SC1-PHE-CORONAVIRUS-2020-2-CNECT
Meccanismo di finanziamento
IA - Innovation actionCoordinatore
60323 Frankfurt Am Main
Germania
Mostra sulla mappa
Partecipanti (21)
1085 Budapest
Mostra sulla mappa
1097 Budapest
Mostra sulla mappa
06123 Perugia
Mostra sulla mappa
10124 Torino
Mostra sulla mappa
50161 KAUNAS
Mostra sulla mappa
3000-075 Coimbra
Mostra sulla mappa
020021 Bucuresti
Mostra sulla mappa
1000 Ljubljana
Mostra sulla mappa
2000 Maribor
Mostra sulla mappa
08007 Barcelona
Mostra sulla mappa
8008 Zurich
Mostra sulla mappa
L’organizzazione si è definita una PMI (piccola e media impresa) al momento della firma dell’accordo di sovvenzione.
60327 Frankfurt Am Main
Mostra sulla mappa
61449 Steinbach
Mostra sulla mappa
33100 Tampere
Mostra sulla mappa
9713 GZ Groningen
Mostra sulla mappa
1000 Bruxelles / Brussel
Mostra sulla mappa
69115 Heidelberg
Mostra sulla mappa
300723 Timisoara
Mostra sulla mappa
NW1 2PG London
Mostra sulla mappa
93053 Regensburg
Mostra sulla mappa
35037 MARBURG
Mostra sulla mappa